BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17016234)

  • 21. Epidemiological aspects of hepatitis C virus infection among HIV-infected individuals in Mato Grosso State, Central Brazil.
    Mussi AD; Pereira RA; Corrêa e Silva Vde A; Martins RM; Souto FJ
    Acta Trop; 2007; 104(2-3):116-21. PubMed ID: 17888391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.
    Bonnet F; Pineau JJ; Taupin JL; Feyler A; Bonarek M; de Witte S; Bernard N; Lacoste D; Morlat P; Beylot J
    J Rheumatol; 2003 Sep; 30(9):2005-10. PubMed ID: 12966606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV and hepatitis C coinfection within the CAESAR study.
    Amin J; Kaye M; Skidmore S; Pillay D; Cooper DA; Dore GJ
    HIV Med; 2004 May; 5(3):174-9. PubMed ID: 15139984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS.
    Tedaldi EM; Hullsiek KH; Malvestutto CD; Arduino RC; Fisher EJ; Gaglio PJ; Jenny-Avital ER; McGowan JP; Perez G;
    Clin Infect Dis; 2003 May; 36(10):1313-7. PubMed ID: 12746778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural predictors of subsequent hepatitis C diagnosis in a UK clinic sample of HIV positive men who have sex with men.
    Turner JM; Rider AT; Imrie J; Copas AJ; Edwards SG; Dodds JP; Stephenson JM
    Sex Transm Infect; 2006 Aug; 82(4):298-300. PubMed ID: 16877578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors of HIV infection and prevalence of co-infections among men who have sex with men in Beijing, China.
    Zhang X; Wang C; Hengwei W; Li X; Li D; Ruan Y; Zhang X; Shao Y
    AIDS; 2007 Dec; 21 Suppl 8():S53-7. PubMed ID: 18172392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
    Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality in siblings of patients coinfected with HIV and hepatitis C virus.
    Hansen AB; Gerstoft J; Kronborg G; Pedersen C; Sorensen HT; Obel N
    J Infect Dis; 2007 Jan; 195(2):230-5. PubMed ID: 17191168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
    Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotypic distribution of hepatitis C among hepatitis C and HIV co-infected patients in Brazil.
    Mendes-Correa MC; Cavalheiro NP; Mello C; Barone AA; Gianini RJ
    Int J STD AIDS; 2008 Sep; 19(9):595-9. PubMed ID: 18725549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection.
    Graham CS; Wells A; Edwards EM; Herren T; Tumilty S; Stuver SO; Samet JH; Nunes D; Horsburgh CR; Koziel MJ
    J Infect Dis; 2007 Mar; 195(6):847-56. PubMed ID: 17299715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.
    Hwang LY; Kramer JR; Troisi C; Bull L; Grimes CZ; Lyerla R; Alter MJ
    Hepatology; 2006 Aug; 44(2):341-51. PubMed ID: 16871571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors associated with hepatitis C among patients co-infected with human immunodeficiency virus: a case-control study.
    Mendes-Correa MC; Barone AA; Gianini RJ
    Am J Trop Med Hyg; 2005 Jun; 72(6):762-7. PubMed ID: 15964961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human T lymphotropic virus 1 and hepatitis C virus as risk factors for inflammatory dermatoses in HIV-positive patients.
    Bonamigo RR; Borges K; Rietjens J; Arenzon S; Blanco LF; Loureiro R
    Int J Dermatol; 2004 Aug; 43(8):568-70. PubMed ID: 15304178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
    Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC
    Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.